Virtu KCG Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$3.42M Buy
41,582
+30,114
+263% +$2.46M 0.1% 109
2017
Q1
$965K Sell
11,468
-8,929
-44% -$715K 0.03% 736
2016
Q4
$1.5M Buy
20,397
+14,464
+244% +$1.08M 0.04% 471
2016
Q3
$476K Sell
5,933
-19,274
-76% -$1.54M 0.01% 1430
2016
Q2
$1.99M Buy
25,207
+17,260
+217% +$1.3M 0.04% 346
2016
Q1
$572K Sell
7,947
-35,834
-82% -$2.71M 0.02% 1050
2015
Q4
$3.69M Buy
+43,781
New +$3.63M 0.06% 204
2015
Q3
Sell
-41,793
Closed -$3.53M 3625
2015
Q2
$3.49M Sell
41,793
-31,399
-43% -$2.39M 0.06% 233
2015
Q1
$5.32M Buy
73,192
+24,981
+52% +$1.78M 0.11% 112
2014
Q4
$3.33M Buy
48,211
+29,345
+156% +$1.98M 0.05% 239
2014
Q3
$1.22M Buy
18,866
+3,194
+20% +$202K 0.02% 795
2014
Q2
$974K Sell
15,672
-12,194
-44% -$728K 0.02% 1204
2014
Q1
$1.64M Sell
27,866
-4,927
-15% -$275K 0.02% 840
2013
Q4
$1.67M Sell
32,793
-46,882
-59% -$2.35M 0.02% 790
2013
Q3
$4.01M Buy
+79,675
New +$4.17M 0.05% 296

Other funds holding LLY

Virtu KCG Holdings's LLY Position: Q2 2017 in Review

Virtu KCG Holdings increased its Eli Lilly (LLY) stake by 263% in Q2 2017, buying an estimated $2.46M and bringing the position to 41,582 shares worth $3.42M. The position accounts for 0.1% of the portfolio, ranked #109.

Virtu KCG Holdings first reported a position in LLY in Q3 2013 and has held it in 15 quarters since. The position peaked at $5.32M in Q1 2015. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Virtu KCG Holdings held 41,582 shares of Eli Lilly worth $3.42M as of Q2 2017.
  • Virtu KCG Holdings bought 30,114 Eli Lilly shares in Q2 2017, an estimated $2.46M.
  • Eli Lilly made up 0.1% of Virtu KCG Holdings's portfolio in Q2 2017, its #109 holding.
  • Virtu KCG Holdings first reported a position in Eli Lilly in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Eli Lilly position peaked at $5.32M in Q1 2015.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.